Unit 10 Treating the Dually Infected Patient: B Family Case Botswana National Tuberculosis Programme Manual Training for Medical Officers.

Slides:



Advertisements
Similar presentations
ISTC Training Modules 2008 Your name Institution/organization Meeting Date.
Advertisements

June 2004 HITCH Training Slide Set #3 Special Considerations in Antiretroviral Therapy.
TUBERCULOSIS. What is Tuberculosis? Tuberculosis (TB) is an infectious disease caused by the bacterium: “Mycobacterium tuberculosis”
HIV and TB Co-infection Unit 14 HIV Basics: A Course for Physicians.
Global Health Case Studies – HIV and Tuberculosis Clinical Pearls in Diagnosis and Management Michael Tuggy, MD.
Case Discussion: TB in Pregnancy December 15, 2010 E. Jane Carter, M.D.
Unit 8: Complications and Special Situations Botswana National Tuberculosis Programme Manual Training for Medical Officers.
TB Presentation for Healthcare Students
In the name of God Fariba Rezaeetalab Assistant Professor.
TB. Areas of Concern TB cases continue to be reported in every state Drug-resistant cases reported in almost every state Estimated million persons.
Why do we test? 1.We want to prevent an outbreak of Tuberculosis in our campus community 2.We want to find those that are affected and get them treated.
Diagnosis of TB.
Tuberculosis (TB) Facts
Respiratory Failure – COPD and Asthma. 59 year old man presents to the ER with a 3 day history of progressively worsening shortness of breath. He has.
Tuberculosis Presented by Vivian Pham and Vivian Nguyen.
Unit 5: IPT Isoniazid TB Preventive Therapy
 Pulmonary Tuberculosis BY: MOHAMED HUSSEIN. Cause  Caused by Mycobacterium tuberculosis (M. tuberculosis)  Gram (+) rod (bacilli). Acid-fast  Pulmonary.
Tuberculosis (T.B.) Randy Kim.
TB 101: TB Basics and Global Approaches. Objectives Review basic TB facts. Define common TB terms. Describe key global TB prevention and care strategies.
 World’s second commonest cause of death  Principal diseases of poverty  The emergence of drug resistant organisms threatens to make Tb incurable.
“Don’t tell me TB is under control!” Understanding TB
CASE 1 55 yo man…Baker HIV+ since 1996 Refused bloodwork over the years as was ‘Feeling fine’ Oral hairy leukoplakia noted on oral biopsy in 2001.
HAIVN Harvard Medical School AIDS Initiative in Vietnam
Pulmonary tuberculosis
Unit 9 Diagnosis and Treatment of Paediatric TB: B Family Case Botswana National Tuberculosis Programme Manual Training for Medical Officers.
1 Respiratory Diseases in HIV-infected Patients HAIVN Harvard Medical School AIDS Initiative in Vietnam.
Unit 7 Treatment of TB: B Family Case Botswana National Tuberculosis Programme Manual Training for Medical Officers.
Unit 6 Diagnosing TB: B Family Case Botswana National Tuberculosis Programme Manual Training for Medical Officers.
Extrapulmonary Site 2 :_____________________ Name (surname, first name) Age (in years) Sex F Alternative address Physical Address (in full) M INTERIM TUBERCULOSIS.
Tuberculosis Egan’s Chapter 22. Mosby items and derived items © 2009 by Mosby, Inc., an affiliate of Elsevier Inc. 2 Tuberculosis (TB) The incidence of.
Nurses SOAR! Training Curricula Series For More Information and Inquiries:
1 Antiretroviral Therapy in HIV-infected Children HAIVN Harvard Medical School AIDS Initiative in Vietnam.
Treatment of Tuberculosis: New Case Case Studies Module 7A2 – March 2010.
Adult Medical-Surgical Nursing Respiratory Module: Tuberculosis.
Screening for TB.
1 Monitoring The Patient on ARV Treatment HAIVN Harvard Medical School AIDS Initiative in Vietnam.
Chapter 4 Cough or difficult breathing Case III. Case study: Mary is an 8 year old girl with cough and weight loss for some weeks.
Clinicopathologic Conference Advanced Update in HIV Medicine and Clinical Research October 1, 2009 Tammy M. Meyers, BA, MBBCh (WITS), FCPaed (SA), Mmed,
By: Michelle Russell.  To become familiar with the disease process of TB Transmission symptoms Precautions  Nursing Diagnoses  Interventions.
HIV/TB – Case Studies David Schlossberg, MD, FACP Medical Director, TB Control Program Philadelphia Department of Health.
NYU Medical Grand Rounds Clinical Vignette Verity Schaye, MD PGY-3 September 15, 2010 U NITED S TATES D EPARTMENT OF V ETERANS A FFAIRS.
Extrapulmonary Site 2 :_____________________ TUBERCULOSIS TREATMENT CARD BOTSWANA NATIONAL TUBERCULOSIS PROGRAMME Date RegisteredIN ToOUT RegisteredIN.
1 HIV Clinical Staging HAIVN Harvard Medical School AIDS Initiative in Vietnam.
Unit 5 Isoniazid Prevention Therapy: B Family Case Botswana National Tuberculosis Programme Manual Training for Medical Officers.
Module 3: Management of Patients on Antiretroviral Therapy Unit 2: Initiation and Monitoring of ART in Adults and Adolescents.
By: Kristen Sieck and Scott Senftner 3rd Period Health Class
Prophylaxis of Opportunistic Infections
NYU Medical Grand Rounds Clinical Vignette Benjamin Eckhardt, MD PGY-3 October 6, 2010 U NITED S TATES D EPARTMENT OF V ETERANS A FFAIRS.
Unit 11 Drug Resistance and MDR-TB: B Family Case Botswana National Tuberculosis Programme Manual Training for Medical Officers.
Scale up TB/HIV activities in Asia Pacific 8-9Aug09 1 TB/HIV collaborative activities in Thailand Sriprapa Nateniyom, M.D. TB Bureau, Department of Disease.
1 Communicating to Other Health Professionals About Your Patient: Doing Case Presentations HAIVN Harvard Medical School AIDS Initiative in Vietnam.
By: Mpho Kontle and Topo Moses. Introduction & Etiology Multi-drug-resistant tuberculosis (MDR-TB) is defined as tuberculosis that is resistant to at.
Immune Reconstitution Inflammatory Syndrome (IRIS)
Tuberculosis By Fion Kung. Objective  Describe tuberculosis  Describe sigh and symptoms of tuberculosis  Describe the nursing diagnosis for tuberculosis.
Treatment Failure HAIVN Harvard Medical School AIDS Initiative in Vietnam.
Inflammation Case Presentation
LEARNING MODULE TITLE SUBTITLE. HISTORY OF PRESENT ILLNESS An 18 year-old woman with no past medical history and no known risks for TB presents with several.
Unit 1: Course Introduction Botswana National Tuberculosis Programme Manual Training for Medical Officers.
Tuberculosis Kasey Johnson & Bethanie Velasco. Outline Vocabulary Background Symptoms Treatment Conclusion Work Cited.
Roundtable. Detection and treatment of TB Andrew Black.
Tuberculosis in Children: Treatment and Monitoring Module 10B - March 2010.
Chapter 4 Cough or difficult breathing Case III
Clinical Case Scenarios
Clinical Case Scenarios
The Respiratory System
Dr Dawood Quiz questions.
Management of Immune Reconstitution Inflammatory Syndrome (IRIS)
Tuberculosis.
Chapter 4 Cough or difficult breathing Case III
Chapter 4 Cough or difficult breathing Case I
Presentation transcript:

Unit 10 Treating the Dually Infected Patient: B Family Case Botswana National Tuberculosis Programme Manual Training for Medical Officers

Slide 2 Unit 10: Case Studies B Family Case: Question 1 Mr. B is on TB retreatment and ART Mr. B returns with nausea, vomiting, and jaundice What do you do for Mr. B?

Slide 3 Unit 10: Case Studies B Family Case: Answer 1 Take a detailed history Do a physical examination Make sure to assess Mr. B’s liver Take blood for liver function, electrolytes, full blood count Bilirubin (100), AST (400 range), ALT (500 range) Admit Mr. B to the hospital for observation Stop all TB and HIV medications, but maintain cotrimoxazole

Slide 4 Unit 10: Case Studies B Family Case: Question 2 1 week later, Mr. B’s LFTs have decreased to less than 2 x ULN What do you do for Mr. B now?

Slide 5 Unit 10: Case Studies B Family Case: Answer 2 Reintroduce TB drugs Monitor liver function tests

Slide 6 Unit 10: Case Studies B Family Case: Question 3 After a 16 day re-introduction, the patient’s LFTs remain < 2x ULN and Mr. B is without jaundice 1.When do you consider starting ART again? 2.Which drugs should Mr. B take?

Slide 7 Unit 10: Case Studies B Family Case: Answer weeks after re-starting full doses of anti- tuberculosis drugs 2.Medications Alluvia, 2 tabs BD Ritonavir, 3 capsules BD Combivir, 1 tab BD * Alluvia is now available in Botswana – it is a tablet form of Kaletra and does not need to be refrigerated

Slide 8 Unit 10: Case Studies B Family Case: Question 5 Why should Mr. B take Alluvia + Ritonvir instead of restarting EFV?

Slide 9 Unit 10: Case Studies B Family Case: Answer 5 EFV can cause heptatotoxicity Since Mr. B is tolerating the ATT, you assume it was the efavirenz that caused the deviation in liver function and jaundice

Unit 10 Treating the Dually Infected Patient: Case Botswana National Tuberculosis Programme Manual Training for Medical Officers

Slide 11 Unit 10: Case Studies Additional Case A 45 year old female named TT with fever for 4 weeks, cough with bloody sputum, sweats and weight loss of 7 kg Sputum is AFB+ Her HIV test is positive and CD4 is 20 cell/cu mm Chest X-ray shows right paratracheal adenopathy

Slide 12 Unit 10: Case Studies Additional Case: Question 1 1.What questions do you ask her? 2.What medications do you start her on?

Slide 13 Unit 10: Case Studies Additional Case: Answer 1 1.Ask her if she is still menstruating TT reports that her menses stopped at 43 years of age 2.Start patient on rifampicin, isoniazid, pyrazinamide and ethambutol plus cotrimoxazole

Slide 14 Unit 10: Case Studies Additional Case: Question 2 TT is started on a four drug TB therapy and is discharged She returns after 1 month Her fevers, night sweats and cough have stopped and she has gained 5kg She is tolerating the TB drugs TB therapy is continued She is started on ARVs including zidovudine, lamivudine and efavirenz Why is she taking efavirenz instead of nevirapine? X-ray shows improvement

Slide 15 Unit 10: Case Studies Additional Case: Answer 2 TT is taking efavirenz instead of nevirapine because she is beyond child bearing age and because efavirenz is the preferred NNRTI for use in patients taking rifampin

Slide 16 Unit 10: Case Studies Additional Case: Question 3 She comes back to your facility 2 weeks after starting ARVs She says that her fever, cough and night sweats have come back She has taken her ARTs as prescribed, but thinks they are making her more sick and she would like to stop them 1.What other information do you want from her history? 2.How would you assess her?

Slide 17 Unit 10: Case Studies Additional Case: Answer 3 1.You want to know whether or not she was adherent to all her medications 2.Assessing TT Check for other signs/symptoms: nausea, vomiting and diarrhoea, which may indicate other infections or malabsorption Check blood pressure, heart rate, temperature, respiratory rate and oxygen saturation Perform labs: sputum smear for AFB, sputum culture, FBC, liver tests, CD4 count, viral load Perform a chest x-ray

Slide 18 Unit 10: Case Studies Additional Case: Question 4 1.What is your differential diagnosis? 2.What do you look for on physical exam?

Slide 19 Unit 10: Case Studies Additional Case: Answer 4 (1) 1.Differential diagnosis TB IRIS Drug-resistant TB Failure of TB therapy due to poor adherence or malabsorption of medications Bacterial pneumonia PCP Drug toxicity

Slide 20 Unit 10: Case Studies Additional Case: Answer 4 (2) 2.Physical examination Close evaluation of the chest Listen for adventitious sounds, symmetrical excursion Check for enlarged lymph nodes Assess for body swelling (oedema) Assess for abdominal distention Asses for jaundice Complete neurologic exam

Slide 21 Unit 10: Case Studies Additional Case: Question 5 (1) TT reports excellent adherence and denies nausea, vomiting or diarrhoea Oxygen saturation is 96% on room air Heart rate, respiratory rate and other vital signs are normal Remainder of physical exam is normal Sputum smear negative Diffuse bilateral infiltrates

Slide 22 Unit 10: Case Studies Additional Case: Question 5 (2) 1.What condition(s) do you suspect now? 2.What is your management plan now?

Slide 23 Unit 10: Case Studies Additional Case: Answer 5 1.Narrowed differential diagnosis TB IRIS PCP Bacterial pneumonia 2.Management Advise her to continue ART and the TB continuation regimen Educate her, using a caring, respectful attitude Ask questions and listen Ensure she understands the benefit of remaining on both treatments Encouragement Schedule her to come back in 1-2 weeks, or sooner if she gets worse

Slide 24 Unit 10: Case Studies Additional Case: Question 6 2 weeks later her symptoms are worse Sputum culture from last visit shows no growth to date Sputum smear is AFB negative Respiratory rate is 28 Oxygen saturation is 90% on room air Crackles heard bilaterally What is your diagnosis? X-ray shows no improvement

Slide 25 Unit 10: Case Studies Additional Case: Answer 6 TB IRIS: Occurs in 10-40% of patients The immune system is likely reacting to dead mycobacteria in the system The inflammation is worsening as her immune system reconstitutes itself on ART Risk factors Starting ARVs within 6 weeks of TB treatment Disseminated, extra-pulmonary disease Low baseline CD4 count Rise in CD4 % Fall in viral load High bacillary burden Source:

Slide 26 Unit 10: Case Studies Additional Case: Question 7 How do you manage TT now?

Slide 27 Unit 10: Case Studies Additional Case: Answer 7 Admit her to hospital Give oxygen FBC, chemistry panel Administer corticosteroids to reduce inflammation If she continues to worsen despite steroid treatment: Stop ART until she has clinically improved (resolution of chest x- ray, respiratory distress) Restart ART once clinically stable Continue TB treatment regimen throughout If a culture turns positive: Suspect drug resistance Do sensitivity testing

Slide 28 Unit 10: Case Studies Additional Case: Question 8 1 week later, TT remains on ART and TB treatment + steroids T.T. reports feeling much better Lungs sound normal Sputum culture is still negative Chest x-ray shows improvement How long should steroids be continued?

Slide 29 Unit 10: Case Studies Additional Case: Answer 8 Consider a 4 week taper May need to restart if IRIS recurs